First Time Loading...

Abbvie Inc
NYSE:ABBV

Watchlist Manager
Abbvie Inc Logo
Abbvie Inc
NYSE:ABBV
Watchlist
Price: 159.62 USD -4.58% Market Closed
Updated: Apr 27, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement
|
Revenue Breakdown

Balance Sheet

134.7B
-1%
Assets
Growth Rates:
1 Year
-3%
3 Years
-11%
5 Years
+127%
7 Years
+104%
10 Years
+361%
124.4B
+0.2%
Liabilities
Growth Rates:
1 Year
+2%
3 Years
-10%
5 Years
+83%
7 Years
+102%
10 Years
+403%
10.4B
-14%
Equity
Growth Rates:
1 Year
-40%
3 Years
-21%
5 Years
-
7 Years
+123%
10 Years
+131%

Balance Sheet Decomposition
Abbvie Inc

134.7B
Assets
124.4B
Liabilities
134.7B
Assets
124.4B
Liabilities
Current Assets 33B
Cash & Short-Term Investments 12.8B
Receivables 11.2B
Other Current Assets 9B
Non-Current Assets 101.7B
Long-Term Investments 304m
PP&E 5B
Intangibles 87.9B
Other Non-Current Assets 8.5B
Current Liabilities 37.8B
Accounts Payable 30.7B
Other Current Liabilities 7.2B
Non-Current Liabilities 86.5B
Long-Term Debt 52.2B
Other Non-Current Liabilities 34.3B

Balance Sheet
Abbvie Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
8 348
8 399
5 100
9 303
7 289
39 924
8 449
9 746
9 201
12 814
Cash Equivalents
8 348
8 399
5 100
9 303
7 289
39 924
8 449
9 746
9 201
12 814
Short-Term Investments
26
8
1 323
486
772
0
30
84
28
2
Total Receivables
3 735
4 730
4 758
5 088
5 384
5 428
8 822
9 977
11 254
11 155
Accounts Receivables
3 735
4 730
4 758
5 088
5 384
5 428
8 822
9 977
11 254
11 155
Other Receivables
0
0
0
0
0
0
0
0
0
0
Inventory
1 124
1 719
1 444
1 605
1 605
1 813
3 310
3 128
3 579
4 099
Other Current Assets
2 848
1 458
3 562
4 741
1 895
2 354
3 562
4 993
4 401
4 932
Total Current Assets
16 081
16 314
16 187
21 223
16 945
49 519
24 173
27 928
28 463
33 002
PP&E Net
2 485
2 565
2 604
2 803
2 883
3 306
6 143
5 872
5 672
5 733
PP&E Gross
2 485
2 565
2 604
2 803
2 883
3 306
6 143
5 872
5 672
5 733
Accumulated Depreciation
4 620
4 769
4 922
5 268
5 513
5 226
5 611
5 617
6 051
6 646
Intangible Assets
1 513
19 709
28 897
27 559
21 233
18 649
82 876
75 951
67 439
55 610
Goodwill
5 862
13 168
15 416
15 785
15 663
15 604
33 124
32 379
32 156
32 293
Long-Term Investments
92
145
1 783
2 090
1 420
93
293
277
241
304
Other Long-Term Assets
1 480
1 149
1 212
1 326
1 208
1 944
3 956
4 122
4 834
7 769
Other Assets
5 862
13 168
15 416
15 785
15 663
15 604
33 124
32 379
32 156
32 293
Total Assets
27 513
N/A
53 050
+93%
66 099
+25%
70 786
+7%
59 352
-16%
89 115
+50%
150 565
+69%
146 529
-3%
138 805
-5%
134 711
-3%
Liabilities
Accounts Payable
6 891
4 531
4 782
5 102
5 572
4 580
8 792
9 939
8 999
10 320
Accrued Liabilities
0
2 987
3 531
3 832
4 726
5 423
9 032
10 217
12 254
15 595
Short-Term Debt
425
406
377
400
3 699
0
34
14
1
0
Current Portion of Long-Term Debt
4 014
2 025
25
6 015
1 609
3 753
8 468
12 481
4 135
7 191
Other Current Liabilities
63
945
1 066
1 292
1 633
1 829
2 335
2 543
4 149
4 735
Total Current Liabilities
11 393
10 894
9 781
16 641
17 239
15 585
28 661
35 194
29 538
37 841
Long-Term Debt
10 538
29 240
36 440
30 953
35 002
62 975
77 554
64 189
59 135
52 194
Deferred Income Tax
159
5 276
6 890
2 490
1 067
1 130
3 646
3 009
2 190
1 952
Minority Interest
0
0
0
0
0
0
21
28
33
37
Other Liabilities
3 681
3 695
8 352
15 605
14 490
17 597
27 607
28 701
30 655
32 327
Total Liabilities
25 771
N/A
49 105
+91%
61 463
+25%
65 689
+7%
67 798
+3%
97 287
+43%
137 489
+41%
131 121
-5%
121 551
-7%
124 351
+2%
Equity
Common Stock
16
17
18
18
18
18
18
18
18
18
Retained Earnings
535
2 248
4 378
5 459
3 368
4 717
1 055
3 127
4 784
1 000
Additional Paid In Capital
4 194
13 080
13 678
14 270
14 756
15 193
17 384
18 305
19 245
20 180
Unrealized Security Profit/Loss
0
47
46
0
10
0
0
0
0
0
Treasury Stock
972
8 839
10 852
11 923
24 108
24 504
2 264
3 143
4 594
6 533
Other Equity
2 031
2 608
2 632
2 727
2 470
3 596
3 117
2 899
2 199
2 305
Total Equity
1 742
N/A
3 945
+126%
4 636
+18%
5 097
+10%
8 446
N/A
8 172
+3%
13 076
N/A
15 408
+18%
17 254
+12%
10 360
-40%
Total Liabilities & Equity
27 513
N/A
53 050
+93%
66 099
+25%
70 786
+7%
59 352
-16%
89 115
+50%
150 565
+69%
146 529
-3%
138 805
-5%
134 711
-3%
Shares Outstanding
Common Shares Outstanding
1 591
1 610
1 593
1 592
1 479
1 479
1 765
1 768
1 769
1 766

See Also

Summary
ABBV intrinsic value, competitors valuation, and company profile.
DCF Valuation
ABBV stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ABBV stock valuation using valuation multiples.
Wall Street Estimates
ABBV price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ABBV stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 131,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.